基于生理学的生物制药建模 (PBBM) 的应用现状和新视野:研讨会报告
Christer Tannergren1, Sumit Arora2, Andrew Babiskin3
1Biopharmaceutics Science, New Modalities & Parenteral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg 43183, Sweden.
Molecular pharmaceutics
|December 16, 2024
概括
基于生理学的生物制药建模 (PBBM) 为创新和仿制药行业推进药品质量. 讨论涉及PBBM在开发中的应用,虚拟生物等价性和监管提交,促进最佳实践.
科学领域:
- 药理学和制药科学 药理学和制药科学
- 药物开发和监管科学 药物开发和监管科学
背景情况:
- 研讨会的第三天专注于生理基础生物制药建模 (PBBM) 药物产品质量的应用.
- 创新,通用和监管观点是讨论的核心.
研究的目的:
- 在药物产品质量方面总结生理基础生物制药建模 (PBBM) 的程序和最佳实践.
- 从行业和监管的角度探索PBBM的当前和未来的应用.
主要方法:
- 关于 PBBM 在仿制药开发中的应用的演讲和案例研究.
- 讨论虚拟生物等价性试验,吸收建模和结肠吸收和体内性能预测.
- 关于特定的 PBBM 应用程序的突破性会议:通用开发,虚拟生物等价性,安全空间/外推和区域/修改版本.
主要成果:
- 在仿制药产品开发和配方桥梁中探索 PBBM 的实用性.
- 对临床药理学和预测延长释放产品体内性能的吸收建模的洞察.
- 关于PBBM的FDA,ANVISA,MHRA,加拿大卫生部,EMA和PMDA的监管观点在提交中.
结论:
- PBBM是药物产品质量的关键工具,在创新和仿制药行业有着多样化的应用.
- 在深入的讨论中,确定了推进 PBBM 应用的最佳实践和关键考虑因素.
- 产业和监管机构之间的合作对于成功实施PBBM至关重要.
相关概念视频
Pharmacokinetic Models: Comparison and Selection Criterion
38
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
38
Model Approaches for Pharmacokinetic Data: Physiological Models
28
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
28
Pharmacokinetic Models: Overview
578
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
578
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
62
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
62
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
56
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
56
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
26
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
26


